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SUMMARY. Pharmaceutical equivalence is an important step towards the confirmation of similarity and
interchangeability among pharmaceutical products, particularly regarding those that will not be tested for
bioequivalence. The aim of this paper is to compare traditional difference testing to two one-side equiva-
lence tests in the assessment of pharmaceutical equivalence, by means of equivalence studies between simi-
lar, generic and reference products of acyclovir cream, atropine sulfate injection, meropenem for injec-
tion, and metronidazole injection. All tests were performed in accordance with the Brazilian Pharma-
copeia or the United States Pharmacopeia. All four possible combinations of results arise in these compar-
isons of difference testing and equivalence testing. Most of the former did not show significant difference,
whereas the latter presented similarity. We concluded that equivalence testing is more appropriate than
difference testing, what can make it a useful tool to assess pharmaceutical equivalence in products that
will not be tested for bioequivalence.
